These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 19428298)

  • 1. Autoimmune disorders of the neuromuscular junction.
    Lang B; Vincent A
    Curr Opin Pharmacol; 2009 Jun; 9(3):336-40. PubMed ID: 19428298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmune mediated neuromuscular junction defects.
    Farrugia ME; Vincent A
    Curr Opin Neurol; 2010 Oct; 23(5):489-95. PubMed ID: 20651592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guidelines for treatment of autoimmune neuromuscular transmission disorders.
    Skeie GO; Apostolski S; Evoli A; Gilhus NE; Illa I; Harms L; Hilton-Jones D; Melms A; Verschuuren J; Horge HW;
    Eur J Neurol; 2010 Jul; 17(7):893-902. PubMed ID: 20402760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on the evaluation and therapy of autoimmune neuromuscular junction disorders.
    Katz J; Barohn RJ
    Phys Med Rehabil Clin N Am; 2001 May; 12(2):381-97. PubMed ID: 11345014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current treatment of neuromuscular diseases.
    Kokontis L; Gutmann L
    Arch Neurol; 2000 Jul; 57(7):939-43. PubMed ID: 10891975
    [No Abstract]   [Full Text] [Related]  

  • 6. Advances and ongoing research in the treatment of autoimmune neuromuscular junction disorders.
    Verschuuren JJ; Palace J; Murai H; Tannemaat MR; Kaminski HJ; Bril V
    Lancet Neurol; 2022 Feb; 21(2):189-202. PubMed ID: 35065041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuromuscular junction autoimmune disease: muscle specific kinase antibodies and treatments for myasthenia gravis.
    Vincent A; Leite MI
    Curr Opin Neurol; 2005 Oct; 18(5):519-25. PubMed ID: 16155434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunology of disorders of neuromuscular transmission.
    Vincent A
    Acta Neurol Scand Suppl; 2006; 183():1-7. PubMed ID: 16637918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody-mediated disorders of neuromuscular transmission.
    Vincent A
    Suppl Clin Neurophysiol; 2004; 57():147-58. PubMed ID: 16106615
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunologic aspects of disorders of neuromuscular transmission. 2. Experimental autoimmune myasthenia gravis and the Lambert-Eaton myasthenic syndrome].
    Andreis I; Lovnićki TJ; Beara N; Taradi M
    Lijec Vjesn; 1994; 116(5-6):158-61. PubMed ID: 7968205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical aspects of neuromuscular transmission disorders.
    Evoli A
    Acta Neurol Scand Suppl; 2006; 183():8-11. PubMed ID: 16637919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pearls and pitfalls in the diagnosis and management of neuromuscular junction disorders.
    Pascuzzi RM
    Semin Neurol; 2001 Dec; 21(4):425-40. PubMed ID: 11774058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myasthenia gravis seronegative for acetylcholine receptor antibodies in South Korea: Autoantibody profiles and clinical features.
    Park KH; Waters P; Woodhall M; Lang B; Smith T; Sung JJ; Kim KK; Lim YM; Kim JE; Kim BJ; Park JS; Lim JG; Kim DS; Kwon O; Sohn EH; Bae JS; Yoon BN; Kim NH; Ahn SW; Oh J; Park HJ; Shin KJ; Hong YH
    PLoS One; 2018; 13(3):e0193723. PubMed ID: 29518096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myasthenia and the neuromuscular junction.
    Gilhus NE
    Curr Opin Neurol; 2012 Oct; 25(5):523-9. PubMed ID: 22892950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ANTIBODIES AND RECEPTORS: From Neuromuscular Junction to Central Nervous System.
    Vincent A
    Neuroscience; 2020 Jul; 439():48-61. PubMed ID: 32194225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myasthenia gravis and related disorders: Pathology and molecular pathogenesis.
    Ha JC; Richman DP
    Biochim Biophys Acta; 2015 Apr; 1852(4):651-7. PubMed ID: 25486268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibodies to ion channels at the neuromuscular junction.
    Lang B; Vincent A
    Autoimmun Rev; 2003 Mar; 2(2):94-100. PubMed ID: 12848965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update in the Management of Myasthenia Gravis and Lambert-Eaton Myasthenic Syndrome.
    Bodkin C; Pascuzzi RM
    Neurol Clin; 2021 Feb; 39(1):133-146. PubMed ID: 33223079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenic Mechanisms and Clinical Correlations in Autoimmune Myasthenic Syndromes.
    Cetin H; Vincent A
    Semin Neurol; 2018 Jun; 38(3):344-354. PubMed ID: 30011414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoimmune disorders of neuromuscular transmission.
    Mahadeva B; Phillips LH; Juel VC
    Semin Neurol; 2008 Apr; 28(2):212-27. PubMed ID: 18351523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.